TLX1 and acute lymphoblastic leukemia: Advances in sequencing have since revealed additional molecular diversity within T-ALL, allowing for subtype classification based on the coordinated dysregulation of gene expression patterns caused by the activation of distinct transcription factors, such as TAL1, LMO1/2, TLX1/3, and NKX2 and others4.